This protein was fused to the E7 antigen of HPV-16 and was used as a DNA vaccine in a murine model, where an increase in CD8+ T lymphocytes for E7 was observed, which counteracted tumor growth in mice, promoting their survival. Here, CD8A is linked to neoplasm.